Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
LifeScan Diabetes Deal Brings $2.1 Billion
Johnson & Johnson’s (NYSE: JNJ) selling spree continued with the divestiture of LifeScan, Inc. for $2.1 billion. LifeScan is a leader in blood glucose monitoring products, serving approximately 20 million patients globally in more than 90 countries. LifeScan markets blood glucose monitoring systems for home and hospital use under the global brand, One Touch. The OneTouch portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions. The buyer, Platinum Equity, made its offer in March 2018 after working with J&J to craft a deal to allow LifeScan to beome a standalone business that would continue to... Read More »
New Enterprise Associates Adds Paladina Health to Its Portfolio
New Enterprise Associates (NEA) has a strong healthcare portfolio, filled with digital health, population health management and physician practices. On June 6, the private equity firm added another physician group, Paladina Health, for a reported $100 million. It’s not surprising that the bidding was “highly competitive,” according to a CNBC source, and that there were other private equity firms in the process. What is interesting is the nod that “a large retailers and pharmacy chain” was also in the hunt. Hello, CVS Health (NYSE: CVS)? Paladina Health, a subsidiary of DaVita Inc. (NYSE: DVA), is a primary care practice with 53 clinics in 10 states. It... Read More »
Myriad Genetics Acquires Counsyl, a Women’s Health Lab
Myriad Genetics (NASDAQ: MYGN) agreed to pay $375 million to acquire privately held Counsyl, Inc., which operates a high-complexity clinical laboratory dedicated to women’s health. Counsyl’s lab services include carrier and non-invasive prenatal screening, including its Foresight Carrier Screen, Prelude Prenatal Screen, Reliant Cancer Screen, as well as supporting services through Counsyl Complete, a suite of solutions that integrate Counsyl screening into clinical workflows and patients’ lives. Since the company’s founding, Counsyl has championed key advances in screening for women and their families, screening more than 850,000 patients, serving more than 17,000... Read More »
Yet Another Physician Specialty Platform Is Created
Physician practices are hot tickets this year, as private investors scramble to put capital to work anywhere they can. Through May 2018, 82 acquisitions have been made public in the Physician Medical Group sector, close to half of all such deals reported in 2017 (166 transactions). Anything that ends in “ology” is getting money thrown at it, some sources tell us. Dermatology practices are in the lead so far, with 18 announced transactions (22%). Ophthalmology and radiology practices are tied for second place, with seven deals each (9%). Primary care is third, with six deals announced (7%). Then there’s pain management practices, with five transactions announced in 2018... Read More »
SwipeSense Acquires iScrub Lite
Just in time for World Hand Hygiene Day (Saturday, May 5, 2018), SwipeSense announced its acquisition of iScrub Lite, the leading mobile application for hand hygiene observation. Yes, that’s real thing. iScrub Lite was conceive and developed by the Computational Epidemiology Research Group at the University of Iowa. It was launched to simplify the error-prone process of recording hand hygiene observations and sharing the results with healthcare professionals. Dr. Philip Polgreen, associate professor of internal medicine and epidemiology at the University of Iowa, said his team created iScrub to serve the infection control community. “However, the costs of updating the service have... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
